-
- Jian Yu
- The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, The Howard Hughes Medical Institute, Baltimore, MD 21231; and University of Pittsburgh Cancer Institute, Hillman Cancer Center, Departments of Pathology and Pharmacology, University of Pittsburgh, Pittsburgh, PA 15213
-
- Zhenghe Wang
- The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, The Howard Hughes Medical Institute, Baltimore, MD 21231; and University of Pittsburgh Cancer Institute, Hillman Cancer Center, Departments of Pathology and Pharmacology, University of Pittsburgh, Pittsburgh, PA 15213
-
- Kenneth W. Kinzler
- The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, The Howard Hughes Medical Institute, Baltimore, MD 21231; and University of Pittsburgh Cancer Institute, Hillman Cancer Center, Departments of Pathology and Pharmacology, University of Pittsburgh, Pittsburgh, PA 15213
-
- Bert Vogelstein
- The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, The Howard Hughes Medical Institute, Baltimore, MD 21231; and University of Pittsburgh Cancer Institute, Hillman Cancer Center, Departments of Pathology and Pharmacology, University of Pittsburgh, Pittsburgh, PA 15213
-
- Lin Zhang
- The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, The Howard Hughes Medical Institute, Baltimore, MD 21231; and University of Pittsburgh Cancer Institute, Hillman Cancer Center, Departments of Pathology and Pharmacology, University of Pittsburgh, Pittsburgh, PA 15213
書誌事項
- 公開日
- 2003-02-06
- DOI
-
- 10.1073/pnas.2627984100
- 公開者
- Proceedings of the National Academy of Sciences
この論文をさがす
説明
<jats:p> Although several genes that might mediate p53-induced apoptosis have been proposed, none have previously been shown to play an essential role in this process through a rigorous gene disruption approach. We used a gene-targeting approach to evaluate p53-mediated death in human colorectal cancer cells. Expression of p53 in these cells induces growth arrest through transcriptional activation of the cyclin-dependent kinase inhibitor <jats:italic>p21</jats:italic> . If <jats:italic>p21</jats:italic> is disrupted via gene targeting, the cells die through apoptosis. If the <jats:italic>PUMA</jats:italic> gene is also disrupted in such cells, apoptosis is prevented. The effects of PUMA on apoptosis were observed after exogenous overexpression of p53 as well as after exposure to hypoxia, a physiologic activator of p53, and DNA damage. The PUMA protein interacts with Bcl-X <jats:sub>L</jats:sub> and promotes mitochondrial translocation and multimerization of Bax. Accordingly, genetic disruption of <jats:italic>BAX</jats:italic> makes cells resistant to the apoptosis resulting from PUMA expression. These results suggest that the balance between PUMA and p21 is pivotal in determining the responses to p53 activation and provide a model for understanding the basis of p53 mutations in human cancer. </jats:p>
収録刊行物
-
- Proceedings of the National Academy of Sciences
-
Proceedings of the National Academy of Sciences 100 (4), 1931-1936, 2003-02-06
Proceedings of the National Academy of Sciences
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1363670320763800448
-
- NII論文ID
- 80015837586
-
- ISSN
- 10916490
- 00278424
-
- データソース種別
-
- Crossref
- CiNii Articles
